SCHOTT Pharma AG & Co. KGaA (VIE:1SXP)

Austria flag Austria · Delayed Price · Currency is EUR
14.92
-0.04 (-0.27%)
Last updated: Dec 23, 2025, 8:55 AM CET
-38.70%
Market Cap2.24B
Revenue (ttm)986.21M
Net Income (ttm)146.45M
Shares Outn/a
EPS (ttm)0.97
PE Ratio15.32
Forward PE15.39
Dividend0.18 (1.22%)
Ex-Dividend DateFeb 4, 2026
Volumen/a
Average Volume18
Open14.78
Previous Close14.96
Day's Range14.78 - 15.00
52-Week Range14.62 - 30.10
Betan/a
RSI23.80
Earnings DateFeb 11, 2026

About VIE:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application... [Read more]

Industry Glass Containers
Founded 1884
Employees 4,811
Stock Exchange Vienna Stock Exchange
Ticker Symbol 1SXP
Full Company Profile

Financial Performance

In 2025, VIE:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.

Financial Statements

News

There is no news available yet.